Novan Inc
Change company Symbol lookup
Select an option...
NOVN Novan Inc
VLAAX Value Line Asset Allocation Fund Investor Class
DODBX Dodge & Cox Balanced Fund
JABAX Janus Henderson Balanced Fund Class T
JBALX Janus Henderson Balanced Fund Class I
ARSVX AMG River Road Small Cap Value Fund Class N
ARSMX AMG River Road Small-Mid Cap Value Fund Class N
TSCSX Thrivent Small Cap Stock Fund Class S
AASMX Thrivent Small Cap Stock Fund Class A
STON StoneMor Partners LP
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Company profile

Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's formulation science enables it to further tune the release of nitric oxide when applied to the skin by using the combinations of inactive ingredients. It is developing SB204 for the treatment of acne vulgaris in Phase III. The Company is developing its product candidate, SB206, for the treatment of external genital and perianal warts in Phase II. It is developing SB208, an investigational topical anti-fungal for the treatment of fungal infections of the skin and nails. It is developing SB204 for the treatment of inflammatory skin diseases. Its pipeline also includes SB414, a topical cream product candidate.

Closing Price
$2.25
Day's Change
0.04 (1.81%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.30
Day's Low
2.15
Volume
(Light)
Volume:
262,280

10-day average volume:
387,780
262,280
  • Prev Close
    2.21
  • Today's Open
    2.25
  • Day's Range
    2.15-2.30
  • Avg Vol (10-day)
    387.8K
  • Last (time)
    4:00p ET 05/24/19
  • Last (size)
    4
  • 52-Wk Range
    0.65 - 3.25
    LowHigh
  • (06/01/18 - 04/17/19)
    30.77%
  • 124.7%
  • Market Cap
    58.7M
  • Shares Outstanding
    26.1M
  • -0.56
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 5.22
  • (% of float 05/15/19)
    2.89

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.